These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1686396

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
    Keepers GA, Casey DE.
    Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
    [No Abstract] [Full Text] [Related]

  • 24. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J, Bohn RL, Mogun H, Gurwitz JH, Monane M, Everitt D, Walker A.
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [Abstract] [Full Text] [Related]

  • 25. Sorting through EPS (extrapyramidal symptoms).
    Blair DT.
    Geriatr Nurs; 1991 Jul; 12(5):244-6. PubMed ID: 1687319
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The pharmacologic treatment of neuroleptic-induced akathisia.
    Fleischhacker WW, Roth SD, Kane JM.
    J Clin Psychopharmacol; 1990 Feb; 10(1):12-21. PubMed ID: 1968470
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The problem of tardive akathisia.
    Gualtieri CT.
    Brain Cogn; 1993 Sep; 23(1):102-9. PubMed ID: 8105819
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Extrapyramidal side effects in patients with Alzheimer's disease treated with low-dose neuroleptic medication.
    Caligiuri MP, Rockwell E, Jeste DV.
    Am J Geriatr Psychiatry; 1998 Sep; 6(1):75-82. PubMed ID: 9469217
    [Abstract] [Full Text] [Related]

  • 35. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH, Jung HY, Kang UG, Jeong SH, Ahn YM, Byun HJ, Ha KS, Kim YS.
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [Abstract] [Full Text] [Related]

  • 36. Neuroleptic induced extrapyramidal symptoms.
    Donlon PT, Stenson RL.
    Dis Nerv Syst; 1976 Nov; 37(11):629-35. PubMed ID: 136337
    [Abstract] [Full Text] [Related]

  • 37. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects.
    Keepers GA, Casey DE.
    Am J Psychiatry; 1991 Jan; 148(1):85-9. PubMed ID: 1670616
    [Abstract] [Full Text] [Related]

  • 38. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
    Dose M.
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
    [Abstract] [Full Text] [Related]

  • 39. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.